Integer Holdings (NYSE:ITGR) posted second-quarter results today that beat the consensus forecast on Wall Street — boosting its 2021 sales outlook amid continued recovery from the COVID-19 pandemic.
The Plano, Texas–based medical device contract manufacturing giant reported profits of $29.4 million, or 89¢ per share, on sales of $312.0 million for the three months ended July 2, 2021. The results mark a major improvement over Q2 2020, when Integer earned $389,000 on sales of 240.1 million.
Adjusted to exclude one-time items, earnings per share were $1.07, 16¢ ahead of The Street, where analysts were looking for EPS of 91¢ on sales of $294.17 million.
Get the full story on our sister site Medical Design & Outsourcing.